WHO ICTRP trial
MAchine Learning in whole Body Oncology
ISRCTN23068310 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN23068310 |
|---|---|
| Public title | MAchine Learning in whole Body Oncology |
| Scientific title | Development and evaluation of machine learning methods in whole body MR with diffusion weighted imaging for staging of patients with cancer |
| Primary sponsor | Imperial College, London - Joint Research Compliance Office |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | United Kingdom;England |
| Conditions | Cancer Cancer |
| Interventions | Research will be carried out at Imperial College London in collaboration with the teams of main studies (NIHR STREAMLINE (colon & lung cancer patients) and CRUK MELT (lymphoma patients)) who have recruited all the patients for diffusion… |
| Registration date | Aug 28, 2015 |
| Target size | 217 |
| Secondary IDs | C/32/2014 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: